null

Naratuximab Biosimilar (Anti-CD37) Antibody (HDBS0046)

SKU:
HDBS0046
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
CD37
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-CD37 naratuximab biosimilar mAb HDBS0046
  • Anti-CD37 naratuximab biosimilar mAb HDBS0046
€399

Description

system_update_altDatasheet

Naratuximab (Anti-CD37) Biosimilar Antibody (HDBS0046)

The anti-CD37 Naratuximab Biosimilar Monoclonal Antibody (HDBS0046) is a cutting-edge product designed for research targeting the CD37 protein, which plays a crucial role in immune regulation and cancer cell growth. This biosimilar antibody, developed as a potential treatment for B-cell malignancies, exhibits high specificity and potency in targeting CD37-expressing cells.Through its unique mechanism of action, this monoclonal antibody effectively targets and eliminates cancerous cells while sparing healthy cells, minimizing side effects commonly associated with traditional cancer treatments. Its high affinity for CD37 makes it a promising candidate for precision medicine approaches in cancer therapy.

This biosimilar monoclonal antibody is a valuable tool for researchers studying CD37 biology, tumor immunology, and targeted cancer therapies. Its ability to selectively target cancer cells and modulate immune responses makes it a key player in the development of novel treatment strategies for hematological malignancies.Overall, the anti-CD37 Naratuximab Biosimilar Monoclonal Antibody (HDBS0046) represents a promising advancement in cancer research and immunotherapy, offering new possibilities for personalized and effective cancer treatment options.

Product Name:Naratuximab (Anti-CD37) Biosimilar Antibody
Size:100 ug
Product SKU:HDBS0046
Target:CD37
Host Species:Chimeric
Reactivity:Human
Recommended Dilution:Flow Cyt 1:100
Antibody Type:Monoclonal
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:IMGN-529, IMGN529, K7153A-SMCC-DM1
Description:Anti-CD37 (naratuximab biosimilar) mAb
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:Powder
ApplicationsFlow Cyt
Antibody Isotype:IgG1
Guarantee:12 months from date of dispatch
Background:Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Synonyms:CD37, TSPAN26, Tspan-26
Uniprot:P11049

Related Products